AC Immune SA (ACIU) shareholders
Close on Nov 17, 2026Market cap $214.68MP/E –Yield –
Ownership
Who owns AC Immune's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BVF Inc. Joint filing with BVF Partners L.P. (19.70%), Mark N. Lampert (19.70%) and 5 more | 19,522,436 | 19.70% | 13G (passive) amendment | Sep 30, 2024 |
| Affiris AG in Liqu | 6,428,100 | 6.50% | 13G (passive) amendment | Dec 13, 2024 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Martin Zuegel | Interim CEO, Director | 71,408 | 0.07% | Jun 15, 2026 |
| Andrea Pfeifer | Chief Executive Officer, Director | 3,834,288 | 3.77% | May 18, 2026 |
| Piergiorgio Donati | Chief Operating Officer | 141,120 | 0.14% | Mar 20, 2026 |
| Christopher James Roberts | Chief Financial Officer | 155,382 | 0.15% | Mar 18, 2026 |
| Thomas Graney | Director | 12,959 | 0.01% | Oct 9, 2026 |
| Roy Ervin Twyman | Director | 92,556 | 0.09% | Jun 15, 2026 |
| Monika Buetler | Director | 71,656 | 0.07% | Jun 15, 2026 |
| Carl Howard June | Director | 67,556 | 0.07% | Jun 15, 2026 |
| Renee Aguiar-Lucander | Director | 51,136 | 0.05% | Jun 15, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Monika Buetler Director | Jun 11, 2026 | Award | +17,751 | – | – | 71,656 |
| Martin Zuegel Interim CEO, Director | Jun 11, 2026 | Award | +33,136 | – | – | 71,408 |
| Renee Aguiar-Lucander Director | Jun 11, 2026 | Award | +16,568 | – | – | 51,136 |
| Carl Howard June Director | Jun 11, 2026 | Award | +16,568 | – | – | 67,556 |
| Roy Ervin Twyman Director | Jun 11, 2026 | Award | +16,568 | – | – | 92,556 |
| Andrea Pfeifer Chief Executive Officer, Director | May 15, 2026 | Sale(10b5-1 plan) | −10,000 | $2.79 | $27.90K | 3,820,288 |
| Andrea Pfeifer Chief Executive Officer, Director | Apr 15, 2026 | Sale(10b5-1 plan) | −10,000 | $3.14 | $31.40K | 3,830,288 |
| Andrea Pfeifer Chief Executive Officer, Director | Apr 15, 2026 | Buy | −10,000 | $3.14 | $31.40K | 3,830,288 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of AC Immune's stock actually held short. Settlement fails (shares not delivered on time) peaked at 29,376 shares on Oct 2, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Andrea Pfeifer Director, Officer | May 15, 2026 | 20,000 | $56.00K | May 15, 2026 | Previously Exercised Stock Options |
| Andrea Pfeifer Officer | Apr 15, 2026 | 10,000 | $31.90K | Apr 15, 2026 | Previously Exercised Stock Options |
| Andrea Pfeifer Officer | Jan 15, 2026 | 30,000 | $110.10K | Jan 15, 2026 | Previously Exercised Stock Options |
| Andrea Pfeifer Officer | Oct 3, 2025 | 45,000 | $140.85K | Oct 3, 2025 | Previously Exercised Stock Options |
| Andrea Pfeifer Officer | Sep 12, 2025 | 35,000 | $83.30K | Sep 12, 2025 | Previously Exercised Stock Options |
| Andrea Pfeifer Officer | Jul 24, 2025 | 20,000 | $46.80K | Jul 24, 2025 | Previously Exercised Stock Options |
| Andrea Pfeifer Officer | Sep 27, 2024 | 40,000 | $148.00K | Sep 27, 2024 | Previously Exercised Stock Options |
| Andrea Pfeifer Officer | Sep 18, 2024 | 20,000 | $69.20K | Sep 18, 2024 | Previously Exercised Stock Options |
| AFFIRIS AG in Liqu 10% Stockholder | May 16, 2024 | 150,000 | $499.50K | May 16, 2024 | Merger/acquisition |
| Andrea Pfeifer Officer | Dec 28, 2023 | 94,000 | $467.18K | Dec 28, 2023 | Ex Opt C comm shs |
| Andrea Pfeifer Officer | Dec 15, 2023 | 95,000 | $352.45K | Dec 15, 2023 | Series B Pref. shares |
| Andrea Pfeifer Officer | Dec 11, 2023 | 20,000 | $73.80K | Dec 11, 2023 | Series B Pref. shares |
| Andrea Pfeifer Officer | Dec 6, 2023 | 20,000 | $70.00K | Dec 6, 2023 | Series B Pref. shares |
| Andrea Pfeifer Officer | Aug 22, 2023 | 16,990 | $52.33K | Aug 22, 2023 | Series B Pref. shares |
| Andrea Pfeifer Officer | Aug 21, 2023 | 1,509 | $4.60K | Aug 21, 2023 | Series B Pref. shares |
See a number that looks wrong?